- Previous Close
35.35 - Open
35.10 - Bid 25.23 x 100
- Ask 44.67 x 100
- Day's Range
34.47 - 35.31 - 52 Week Range
25.12 - 55.75 - Volume
808,202 - Avg. Volume
498,535 - Market Cap (intraday)
1.637B - Beta (5Y Monthly) 0.85
- PE Ratio (TTM)
129.67 - EPS (TTM)
0.27 - Earnings Date Apr 30, 2025 - May 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
51.00
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.
www.omnicell.com3,670
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: OMCL
View MorePerformance Overview: OMCL
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OMCL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OMCL
View MoreValuation Measures
Market Cap
1.64B
Enterprise Value
1.64B
Trailing P/E
129.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.46
Price/Book (mrq)
1.32
Enterprise Value/Revenue
1.47
Enterprise Value/EBITDA
18.18
Financial Highlights
Profitability and Income Statement
Profit Margin
1.13%
Return on Assets (ttm)
0.16%
Return on Equity (ttm)
1.03%
Revenue (ttm)
1.11B
Net Income Avi to Common (ttm)
12.53M
Diluted EPS (ttm)
0.27
Balance Sheet and Cash Flow
Total Cash (mrq)
369.2M
Total Debt/Equity (mrq)
30.77%
Levered Free Cash Flow (ttm)
146.87M